#

Metabolic dysfunction-associated steatohepatitis (MASH)

  • Compensation to be determined
  • 18 study visits
#

18+ Years

#
Male or Female
#
Smoker & Non-Smoker

Description

The is a 7-year I study testing the safety and effectiveness of a weekly injection of an investigational product compared to a placebo in people with MASH and liver fibrosis.

Is this not what you are looking for?
Check out our other studies.

Related Studies

#

Metabolic dysfunction-associated steatohepatitis (MASH)

  • Compensation to be determined
  • 18 study visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
#

Diabetic Foot Ulcer

  • Compensation to be determined
  • 16 study visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
#

Ulcerative Colitis

  • Compensation to be determined
  • 17 study visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
© 2025 Access Research Institute. All Rights Reserved